Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00094692 · ClinicalTrials.gov registry record · Phase 3
An Evaluation of Treatment of Amblyopia in Children 7 To <18 Years Old
A Phase 3 study, sponsored by Jaeb Center for Health Research.
- Completed
- Registry status
- Phase 3
- Development phase
- 507
- Enrollment target
NCT00094692: Completed Phase 3 study, sponsored by Jaeb Center for Health Research.
NCT00094692 is a Phase 3 study that has completed, run by Jaeb Center for Health Research. The registered enrollment target is 507 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (34% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00094692, a Phase 3 study, has completed, sponsored by Jaeb Center for Health Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 507 participants
- Enrollment target
Study Summary
The goals of this study are: * To determine the response rate of treatment of amblyopia in 7 to \<18 year olds. * To determine the frequency of recurrence of amblyopia in 7 to \<18 year olds after discontinuation of amblyopia treatment.
Interventions
- DEVICE Eye patch
- DEVICE spectacles
- DRUG atropine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 507 participants |
| Start Date | 2002-10 |
| Est. Completion | 2005-12 |
| Phase | Phase 3 |
What the finished NCT00094692 record still lists
NCT00094692 is an interventional study that assigns participants to a tested intervention. The registered 507 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (34% lower).
The record links to 0 conditions, and to 3 interventions - of which Eye patch is the first listed.
NCT00094692 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00094692 about?
NCT00094692 is a clinical study titled "An Evaluation of Treatment of Amblyopia in Children 7 To <18 Years Old". The goals of this study are: * To determine the response rate of treatment of amblyopia in 7 to \<18 year olds. * To determine the frequency of recurrence of amblyopia in 7 to \<18 year olds after discontinuation of amblyopia treatment.
What is the current status of trial NCT00094692?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 507 participants. The study started on 2002-10. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00094692?
The interventions under investigation include: Eye patch (DEVICE), spectacles (DEVICE), atropine (DRUG).
Who is sponsoring clinical trial NCT00094692?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00094692's enrollment target sits among peer trials
507 739th of 2000 higher than 1,260 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06164717 · 507 participants · NA
Behavioral and Neural Characteristics of Adaptive Speech Motor Control
- NCT02115295 · 508 participants · Phase 2
Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia
- NCT04692675 · 508 participants · NA
Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer
- NCT07391657 · 508 participants · Phase 3
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia